NAN OTECHN OLOGY
immunogenicity, prolongs plasma half-life, and enhances protein stability.
Polymer-drug conjugation promotes tumor
targeting through the enhanced
permeability and retention effect, and at
the cellular level following endocytic
capture, allows lysosomotropic drug
delivery. Ceramic nanoparticles are
inorganic systems with porous
characteristics that have recently emerged
as drug vehicles. 4
Dendrimers
Drug Delivery Technology February 2009 Vol 9 No 2
Dendrimers have emerged as an
important class of drug-encapsulating
nanoparticles as a result of their unique
architecture and macromolecular
characteristics. Dendrimers are synthetic,
highly branched, spherical, monodispersed
macromolecules with an average diameter
of 1.5 to 14. 5 nm. A typical dendrimer
molecule consists of an initiator core,
highly branched layers composed of
repeating units, and multiple active
terminal groups. The architectural design
of dendrimers provides a high level of
control over the dendrimer size, shape,
branching length, and surface functionality.
Biodegradable polyester dendrimers
based on 2,2-bis(hydroxymethyl)-
propanoic acid monomers have been
developed for intracellular release of
doxorubicin after hydrolysis of the
hydrazone linkage. The promising
properties of polyester dendrimers as a
drug delivery system has led to further
studies based on tunable architectures and
molecular weights to optimize tumor
accumulation. In a comparative study with
Doxilin C- 26 colon carcinoma-bearing
mice, the polyester dendrimer drug
conjugate shows similar efficacy to the
doxorubicin-liposome formulation. 5
Nucleic Acid-Based
Nanoparticles
In nucleic acid-based nanoparticles,
50
DNA and RNA macromolecules can be
used as substrates for developing
therapeutic and imaging nanocarriers. A
multivalent DNA delivery vehicle, with an
average size of 100 nm, was recently
reported for simultaneous targeted drug
delivery, imaging, and gene therapy.
Targeted multifunctional RNA
nanoparticles ( 25 to 40 nm) have also
been developed with a trivalent RNA core,
RNA aptamers for targeting, and siRNAs
for therapeutic effect. 6
Polymeric Nanoshells
Polymeric nanoshells consist of
diblock copolymers that can be assembled
into a core/shell structure. In general,
nanoshells are made by self-assembly of
oppositely charged polymers covering the
surface of the drug’s nanoparticles.
Therefore, the drug-release rate is
controlled by the chemistry of the
polymers and the diffusion coefficient
through the polymeric layer. For example,
nanoshells encapsulating doxorubicin have
been synthesized using amphiphilic
tercopolymer poly(N-isopropylacrylamide-co-N,N-
dimethylacrylamide-co-10-
undecenoicacid) that can trigger
intracellular doxorubicin release at pH 6. 6.
Nanoparticle
Liposome
Small Polymer
Size
100-200 nm
~200 kDa
TABLE 1
Toxicity
Low
Low
Status
Clinical use
Research
Application
Delivery
Delivery
Dendrimer
2-6 nm depending on
generation number
Variable
depending on
cell type
Phase I
Delivery
Virus
Hybrid System
QD-Virus
Metal Core
Dendrimers
Nanoshells
Quantum Dots
Carbon
Nanotubes
30-100 nm
-
Variable
2-4 nm for gold
60-400 nm
2-10 nm
High
-
-
-
Non-toxic
Toxic
Expected to
be non-toxic
Phase II
-
Research
Research
Research
Commercial
Research
Delivery
-
Imaging Delivery
Delivery
Imaging, Treatment
Sensing, Imaging
Delivery, Sensing
Single-Walled
1-2 nm diameter,
variable length
-
-
-
20-25 nm diameter,
Multi-Walled -
variable length
Variable
Nanowires NA
length/diameter
Nanoparticle size, toxicity, status, and application. 6
-
-
Research
Sensing